ArticlePLoS neglected tropical diseases2012
Scientific standards and the regulation of genetically modified insects.
Article in PLoS neglected tropical diseases, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- A typology of community and stakeholder engagement based on documented examples in the field of novel vector control.PLoS neglected tropical diseases · 2019Pooled it
- Is Dengue Vector Control Deficient in Effectiveness or Evidence?: Systematic Review and Meta-analysis.PLoS neglected tropical diseases · 2016Pooled it
- Willingness to accept and participate in a Microsporidia MB-based mosquito release strategy: a community-based rapid assessment in western Kenya.Malaria journal · 2024Article
- Unigems: plasmids and parts to facilitate teaching on assembly, gene expression control and logic inAccess microbiology · 2023Article
- Effect ofInsects · 2022Article
- Elimination of a closed population of the yellow fever mosquito, Aedes aegypti, through releases of self-limiting male mosquitoes.PLoS neglected tropical diseases · 2022Article
- Oxitec and MosquitoMate in the United States: lessons for the future of gene drive mosquito control.Pathogens and global health · 2021Article
- Hybrid mosquitoes? Evidence from rural Tanzania on how local communities conceptualize and respond to modified mosquitoes as a tool for malaria control.Malaria journal · 2021Article
- A Review:Vaccines · 2021Review
- Synthetic Mutualism and the Intervention Dilemma.Life (Basel, Switzerland) · 2019Review
- Ethics of community engagement in field trials of genetically modified mosquitoes.Developing world bioethics · 2018Article
- GM insect pests under the Brazilian regulatory framework: development and perspectives.BMC proceedings · 2018Review
- Transcriptional effects of a positive feedback circuit in Drosophila melanogaster.BMC genomics · 2017Article
- Transmission-blocking strategies: the roadmap from laboratory bench to the community.Malaria journal · 2016Review
- Engaging scientists: An online survey exploring the experience of innovative biotechnological approaches to controlling vector-borne diseases.Parasites & vectors · 2015Article
- Aedes aegypti Control Strategies in Brazil: Incorporation of New Technologies to Overcome the Persistence of Dengue Epidemics.Insects · 2015Review
- Factors influencing stakeholders attitudes toward genetically modified aedes mosquito.Science and engineering ethics · 2015Article
- Review
- Building Better Environmental Risk Assessments.Frontiers in bioengineering and biotechnology · 2015Review
- Geographic expansion of the invasive mosquito Aedes albopictus across Panama--implications for control of dengue and Chikungunya viruses.PLoS neglected tropical diseases · 2015Article
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.